Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) saw unusually-high trading volume on Tuesday . 853,550 shares changed hands during trading, an increase of 61% from the previous session’s volume of 529,446 shares.The stock last traded at $8.5190 and had previously closed at $9.12.
Analyst Ratings Changes
A number of research analysts have weighed in on TRLV shares. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. Weiss Ratings assumed coverage on shares of Trulieve Cannabis in a research note on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Reduce”.
Read Our Latest Stock Report on Trulieve Cannabis
Trulieve Cannabis Stock Performance
Insider Activity
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Featured Stories
- Five stocks we like better than Trulieve Cannabis
- How Does D-Wave’s New Simulator Change the Quantum Computing Landscape?
- Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock
- The Biotech Sector Looks Ready for a Multi-Year Breakout—Here’s What to Watch.
- How Intel Is Packaging the Future of American Chips
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
